Objective: to develop a new liver-on-chip model that includes a relevant 3D matrix for hepatic cell growth and function with the use of of BIOMIMESYS® Liver hydroscaffold for a physiological 3D hepatocyte culture.

Ask for high quality link by putting your email below

Ask for high quality link by putting your email below

Please, double check your email!

View and download on Slideshare (low quality) https://www.slideshare.net/hcspharma/development-of-a-new-liveronchip-including-biomimesys-technology-for-mimicking-the-liver-extracellular-matrix-first-results-and-perspectives-165363388

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Artifical Intelligence and HCS in 3D cell culture: the perfect team to revolutionize drug discovery! | HCS Pharma · September 10, 2019 at 2:05 pm

[…] Organ-on-a-chip technology using BIOMIMESYS® […]

Kick-off meeting of ANR-funded project MIMLIVEROnChip | HCS Pharma · October 8, 2019 at 2:02 pm

[…] Don’t forget to take a look at our poster : “Development of a new liver-on-chip including BIOMIMESYS® technology for mimicking the liver extrace…“ […]

Feedback from Molecular Devices' User Meeting in Leiden | HCS Pharma · March 24, 2020 at 2:01 pm

[…] NO, BIOMIMESYS is not a hydrogel and YES, it can be cast in biochips! […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.